跳至主要内容
临床试验/ACTRN12621000261819
ACTRN12621000261819招募中未知

investigating the patient reported outcomes and medication compliance of newly diagnosed and relapsed patients with myeloma aged 65 and older under the case management of a nurse specialist led program.

BMS-celgene0 个研究点目标入组 150 人开始时间: 2021年3月10日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of Myeloma according to the WHO (2008) classification, aged 65years and over
  • MGUS patients progressed to Myeloma needing treatment
  • Relapsed Myeloma patients needing treatment
  • Capacity to understand and voluntarily sign an informed consent form
  • Able to be followed at the Royal Adelaide Hospital/The Queen Elizabeth Hospital

排除标准

  • Primary Haematologist does not practice at the Royal Adelaide Hospital/ The Queen Elizabeth Hospital
  • patients <65 years of age
  • Any significant condition that would confound the collection or interpretation of data from the study

研究者

发起方
BMS-celgene

相似试验